Morgan Stanley Phasebio Pharmaceuticals Inc C Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
N/A
-11,003 Reduced 10.31%
95,763 $17,000
Q2 2022

Oct 27, 2022
SELL
N/A
-34,102 Reduced 24.21%
106,766 $64,000
Q2 2022

Aug 15, 2022
SELL
N/A
-34,102 Reduced 24.21%
106,766 $64,000
Q1 2022

Oct 27, 2022
BUY
N/A
34,102 Added 31.94%
140,868 $186,000
Q1 2022

May 13, 2022
SELL
N/A
-130,409 Reduced 48.07%
140,868 $186,000
Q4 2021

Feb 14, 2022
BUY
N/A
122,115 Added 81.87%
271,277 $708,000
Q3 2021

Nov 15, 2021
BUY
N/A
149,162 New
149,162 $464,000

About PHASEBIO PHARMACEUTICALS INC C

PHASQ Quotes by TradingView
  • Ticker PHASQ
More about PHASQ
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email